Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Alexapath
AddedFeb 16, 2024
UpdatedJun 18, 2026
Alexapath

Alexapath

Pre-Seed

AlexaPath: Revolutionizing medical imaging with our smartphone-based microscopic diagnostic system.

HQ
New York City, NY, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to democratize medical imaging, Alexapath leverages smartphone technology to provide accessible microscopic diagnosis globally. The core vision is to overcome barriers in medical diagnostics by using a compact, innovative system that integrates a smartphone app and Internet of Things connectivity. This patent-pending Telepathology System enables users to perform lab-quality diagnostics with a device that fits in their pocket, making it particularly valuable in remote or underserved regions.

Alexapath has garnered attention and accolades for its groundbreaking approach to medical imaging. The company’s solution has been recognized with awards for its potential to transform healthcare delivery. By making high-quality diagnostic tools more accessible, Alexapath is poised to significantly impact global health, particularly in areas where traditional lab infrastructure is lacking.

Alexapath - Similar Companies

Instapath Inc. logo

Instapath Inc.

instapathbio.com

Steth IO logo

Steth IO

stethio.com

Accessible Diagnostics logo

Accessible Diagnostics

Airilabs logo

Airilabs

Pathware logo

Pathware

pathware.com

Brightlamp logo

Brightlamp

MobileMedTek logo

MobileMedTek

Pons logo

Pons

ponstech.co

ChestAi logo

ChestAi

AlemHealth logo

AlemHealth

alemhealth.com

Morphle Labs logo

Morphle Labs

morphlelabs.com

Scanbase logo

Scanbase

scanbase.com

CurieDx logo

CurieDx

curiedx.com

Luminostics logo

Luminostics

Pathology Watch logo

Pathology Watch

pathologywatch.com

Alexapath - Quick Facts

Who are Alexapath's competitors?

Companies similar to Alexapath include Instapath Inc., Steth IO, Accessible Diagnostics and Airilabs.

When was Alexapath founded?

Alexapath was founded in 2015.

Where is Alexapath's headquarters located?

Alexapath's headquarters is located in New York City, NY, US.

When was Alexapath's last funding round?

Alexapath's most recent funding round was for $50k (USD) in January 2020.

How much has Alexapath raised to-date?

As of Jan 15, 2020, Alexapath has raised a total of $50k (USD).

How many employees does Alexapath have?

Alexapath has 30 employees as of Feb 4, 2024.

Alexapath - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • AI
  • Telemedicine
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Medical Imaging
Tags
  • Healthtech
  • IoT
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 12 more industry codes
NAICS
  • 334100Computer and Peripheral Equipment Manufacturing
  • 513200Software Publishers
  • 330000Manufacturing
  • 510000Information
  • 334000Computer and Electronic Product Manufacturing
  • 513000Publishing Industries
  • 334110Computer and Peripheral Equipment Manufacturing
  • 513210Software Publishers
SIC
  • 5700Home Furniture, Furnishings, And Equipment Stores
  • 5730Radio, Television, Consumer Electronics, And Music Stores
  • 5734Computer And Computer Software Stores
  • 7372Prepackaged Software